Total Return chart Lineage Cell Therapeutics, Inc.
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Market Closed -
NYSE
21:00:00 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.010 USD | -0.98% |
|
-6.48% | -39.52% |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
